Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

https://soho2018.org/

 

Session VIII: Non-Hodgkin Lymphoma
17:19

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Follicular Lymphoma - Bendamustine and Rituximab as Preferred Treatment and Maintenance Therapy

FEATURING Mathias J. Rummel
  • 359 views
  • October 25, 2018
  • 2
18:05

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Managing High Risk/Relapsed Follicular Lymphoma

FEATURING Nathan H. Fowler
  • 243 views
  • October 25, 2018
  • 1
16:02

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

DEBATE: Do We Need Maintenance Anti-CD20 Antibody After RCHOP/R-Chemo For Newly Diagnosed Follicular Lymphoma? Pro

FEATURING Mathias J. Rummel
  • 114 views
  • October 25, 2018
12:43

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Advances in the Treatment of Primary Central Nervous System Lymphoma

FEATURING Christopher J. Melani
  • 118 views
  • October 25, 2018
16:44

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

How I Treat Double Hit Lymphoma

FEATURING Kieron Dunleavy
  • 396 views
  • October 25, 2018
  • 1
08:33

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Oral Abstract NHL 049: Second Primary Malignancies in T-cell Neoplasm Survivors: An United States Population-Based Analysis

FEATURING Anuhya Kommalapati
  • 15 views
  • November 5, 2018
07:40

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Oral Abstract NHL 088: Angiogenesis’ Related Polymorphism Emerges as Prognostic Marker in de Novo Large B-cell Lymphoma Patients

FEATURING Angelo Brito
  • 127 views
  • November 5, 2018
  • 1
06:36

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Oral Abstract NHL 102: Axicabtagene Ciloleucel in Patients With Refractory Large B Cell Lymphoma: Outcomes by Prior Lines of Therapy in the Pivotal Phase 2 Study, ZUMA-1

FEATURING Sattva Neelapu
  • 106 views
  • October 25, 2018
  • 1
06:56

Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Oral Abstract NHL 122: Durability of Response in Patients With Refractory Large B Cell Lymphoma Treated With Axicabtagene Ciloleucel in the Pivotal Phase 2 Study, ZUMA-1

FEATURING Sattva Neelapu
  • 27 views
  • October 25, 2018